Company Beta Drugs Limited

BETA

INE351Y01019

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sector Other Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:43:47 2024-05-03 am EDT			5-day change	1st Jan Change
1,348 ^INR	-2.51%		+3.15%	-8.33%

2023	Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
2023	Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	CI

Beta Drugs Limited is an India-based company, which is engaged in manufacturing of the wide range of anti-cancer drugs in India. The Company operates through manufacturing of Oncology medicines segment. The Company offers a portfolio consisting of approximately 50 products catering to various oncology diseases, including breast, lung, head, and neck, colorectal, ovarian, gastric, brain, testicular renal, prostate, leukemia, lymphoma, myeloma, supportive. The Companyâs oncology portfolio includes various brands, such as AB-PACLI, ADBIRON, ADCARB, ADCIST, Adlante, ADLEAP, ADMIDE, ADOXI, CAPAD, ARBAZ, FISTENT, BUSFAN, Triodelta and others. The Company's subsidiaries include Adley Lab Limited, Adley Formulations Private Limited.

Number of employees: 315

INR in Million	2022	Weight	2023	Weight	Delta
Oncology Medicines 100.0 %	1,838	100.0 %	2,271	100.0 %	+23.54%

INR in Million	2022	Weight	2023	Weight	Delta
India 100.0 %	1,838	100.0 %	2,271	100.0 %	+23.54%

Managers	Title	Age	Since
Rahul Batra CEO	Chief Executive Officer	40	14-07-31
Varun Batra CEO	Chief Executive Officer	38	14-07-31
Nipun Arora DFI	Director of Finance/CFO	40	21-03-04
Sanjeev Chopra CTO	Chief Tech/Sci/R&D Officer	-	-
Sandeep Gupta CTO	Chief Tech/Sci/R&D Officer	-	-
Surendra Kumar Yadav CTO	Chief Tech/Sci/R&D Officer	51	17-12-31
Rajni Brar CMP	Compliance Officer	38	17-07-16
Ashutosh Shukla BRD	Director/Board Member	46	19-03-26
Sudhir Rajput SAM	Sales & Marketing	48	17-06-30

Members of the board	Title	Age	Since
Balwant Singh BRD	Director/Board Member	54	14-07-31
Varun Batra CEO	Chief Executive Officer	38	14-07-31
Rahul Batra CEO	Chief Executive Officer	40	14-07-31
Manmohan Khanna BRD	Director/Board Member	70	17-07-25
Rohit Parti BRD	Director/Board Member	48	17-07-25
Seema Chopra BRD	Director/Board Member	48	19-07-31
Ashutosh Shukla BRD	Director/Board Member	46	19-03-26

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	9,613,790	8,563,005 ( 89.07 %)	0	89.07 %

Name	Equities	%	Valuation
Neeraj Batra 65.96 %	6,341,663	65.96 %	94 M ₹
Suryavanshi Commotrade Pvt Ltd. 6.737 %	647,644	6.737 %	10 M ₹
Ashish Kacholia 5.783 %	556,000	5.783 %	8 M ₹
BSAS Infotech Ltd. 1.273 %	122,400	1.273 %	2 M ₹
Onkar Singh 1.048 %	100,800	1.048 %	1 M ₹
Rahul Batra 0.4124 %	39,650	0.4124 %	586 531 ₹
Varun Batra 0.3456 %	33,230	0.3456 %	491 562 ₹

Beta Drugs Ltd.

SOC-184, Sector-5

134114, Panchkula

+91 17 2258 5481

http://www.betadrugslimited.com

Name	Category and Sector
Adley Labs Ltd. Adley Labs Ltd. Pharmaceuticals: MajorHealth Technology Adley Labs Ltd. manufactures cancer drugs. The private company is based in Chandigarh, India.	Pharmaceuticals: Major

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
BETA DRUGS LIMITED	-8.33%	155M
ELI LILLY AND COMPANY	+26.08%	662B
NOVO NORDISK A/S	+21.85%	546B
JOHNSON & JOHNSON	-4.77%	359B
MERCK & CO., INC.	+16.97%	323B
ABBVIE INC.	+5.69%	290B
ASTRAZENECA PLC	+13.68%	234B
NOVARTIS AG	+3.65%	198B
ROCHE HOLDING AG	-11.12%	194B
PFIZER, INC.	-3.40%	157B

Other Pharmaceuticals